The results showed that the levels of TNF-α, MCP-1, IL-8, and IL-1β, the proteins with proinflammatory effects, were significantly decreased compared with those in GDM pregnant mice, indicating that the ω-3 FAs treatment reduces the systematic inflammatory response of GDM pregnant mice (Figure 4a–d). The gene discussed is CCL2; the disease is gestational diabetes.